# Anti-Migration System for Anti-reflux Oeso-gastric Stent (ANTIMIG)

> **NCT05431738** · NA · RECRUITING · sponsor: **Société Française d'Endoscopie Digestive** · enrollment: 180 (estimated)

## Conditions studied

- Stent Migration
- GastroEsophageal Cancer

## Interventions

- **DEVICE:** Gastroesophageal stent placement

## Key facts

- **NCT ID:** NCT05431738
- **Lead sponsor:** Société Française d'Endoscopie Digestive
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-01
- **Primary completion:** 2025-09-01
- **Final completion:** 2025-09-01
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2024-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05431738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05431738, "Anti-Migration System for Anti-reflux Oeso-gastric Stent (ANTIMIG)". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT05431738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*